Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial

Solomon Jo, Agnes Juhasz, Keqiang Zhang, Christopher Ruel, Sofia Loera, Sharon P. Wilczynski, Yun Yen, Xiyong Liu, Joshua Ellenhorn, Dean Lim, Benjamin Paz, George Somlo, Nayana Vora, Stephen Shibata

研究成果: 雜誌貢獻文章

40 引文 斯高帕斯(Scopus)

摘要

The aim of this study was to determine the presence of high-risk HPV-16 in patients with HNSCC, assess the impact of HPV status on treatment response and survival in this select cohort treated with combined modality therapy and to identify the differences in HIF-1α and VEGF expression in HPV-positive and -negative tumors. Patients and Methods: Patients had resectable, untreated stage III, IV HNSCC of the oral cavity, oropharynx, hyopharynx or larynx, and stage II cancer of the base of tongue, hypopharynx and larynx. HPV status was determined by conventional PCR in fresh frozen biopsy samples and by Taqman PCR assay on formalin-fixed, paraffin-embedded specimens. HIF-1α and VEGF expression were assessed by quantitative real-time PCR (RT-PCR). Multivariate Cox proportional hazards regression analysis was used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) based on HPV status. Results: HPV-16 was detected in 14 of 24 evaluable cases. There were no significant differences in response rates after neoadjuvant chemotherapy (86% vs. 90%) in HPV-positive and HPV-negative patients, respectively. There was a trend toward better progression-free (HR=0.15, 95% CI=0.002-12.54; p=0.06) and overall survival (HR=0.14, 95% CI=0.001-14.12; p=0.10) for HPV-positive patients. In a subset of 13 fresh frozen samples, RT-PCR revealed a significant increase in VEGF mRNA levels in HPV-positive tumors (p<0.01).No difference was seen for HIF-1α expression. Conclusion: HPV presence portended a better prognosis in patients with oropharyngeal SCC treated with a multimodality treatment in a prospective clinical trial. The level of VEGF mRNA was up-regulated in HPV-16-positive tumors possibly through an HIF-1 independent manner.

原文英語
頁(從 - 到)1467-1474
頁數8
期刊Anticancer Research
29
發行號5
出版狀態已發佈 - 五月 1 2009
對外發佈Yes

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

指紋 深入研究「Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial」主題。共同形成了獨特的指紋。

  • 引用此

    Jo, S., Juhasz, A., Zhang, K., Ruel, C., Loera, S., Wilczynski, S. P., Yen, Y., Liu, X., Ellenhorn, J., Lim, D., Paz, B., Somlo, G., Vora, N., & Shibata, S. (2009). Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. Anticancer Research, 29(5), 1467-1474.